Avirmax Biopharma

Product Pipline

Avirmax Biopharma Inc. is at preclinical stage of biotherapeutics development using rAAV delivery system. Currently, it is developing multiple rAAV candidates. The following are examples of Avirmax Biopharma’s product pipelines under development.

  • Program
  • Indication
  • Lead Design & Production
  • AAV - Vector
  • Biochemical
  • Potency
  • Preclinical
  • IND - Enabling
  • Phase 1
  • Commercial Rights
  • Milestone

iCare CNV

wAMD, DME, PCV

ABI-110
0%
ABI-112
0%

IND 2H23

GA

ABI-201
0%

iCare   GA

dAMD

ABI-210
0%

dAMD

ABI-220
0%

iCare NIU

NIU, uvCNV, UMO

ABI-107 , ABI-108
0%

iCare RGC

Glaucoma

ABI-902
0%

PIND 2H23

AMD = Age-Related Macular Degeneration
DME = Diabetic Macular Edema
CNV = Choroidal Neovascularization
PCV = Polypoidal Choroidal Vasculopathy
RVO= Retinal Vein Occlusion
GA = Geographic atrophy